Abstract
Restriction fragment length polymorphism haplotyping of mutated and normal phenylalanine hydroxylase (PAH) alleles in 49 Dutch phenylketonuria (PKU) families was performed. All mutant PAH chromosomes identified by haplotyping (n = 98) were screened for eight of the most predominant mutations. Compound heterozygosity was proven in 40 kindreds. Homozygosity was found for the IVS12nt1 mutation in 5 families, and for the R158Q and IVS10nt546 mutations in one family each. All patients from these families suffer from severe PKU, providing additional proof that these mutations are deleterious for the PAH gene. Genotypical heterogeneity was evident for mutant haplotype 1 (n = 27) carrying the mutations R261Q (n = 12), E280K (n = 4), P281L (n = 1) and unknown (n = 10), and likewise for mutant haplotype 4 (n = 30) carrying the mutations R158Q (n = 13), Y414C (n = 1) and unknown (n = 16). Mutant haplotype 3 (n = 20), in tight association with mutation IVS12nt1, appeared to be in strong linkage disequilibrium (LDE) with its normal counterpart allele (n = 4). Mutant haplotype 6 (n = 4), in tight association with the IVS10nt546 mutation, showed moderate LDE with its counterpart allele (n = I). The distribution of the mutant PAH haplotypes 1, 3 and 4 among the Dutch PKU population resembles that in other Northern and Western European countries, but it is striking that mutant haplotype 2 and its associated mutation R408W is nearly absent in The Netherlands, in strong contrast to its neighbouring countries.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abadie V, Lyonnet S, Maurin N, Berthélon M, Caillaud C, Giraud F, Mattel J-F, Rey J, Munnich A (1989) CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics 5:936–939
Avigad S, Kleiman S, Weinstein M, Cohen BE, Schwartz G, Woo SLC, Shilo Y (1991) Compound heterozygosity in nonphenylketonuria hyperphenylalaninemia: the contribution of mutations for classical phenylketonuria. Am J Hum Genet 49:393–399
Daiger SP, Chakraborty R, Reed L, Fekete G, Schuler D, Berenssi G, Nasz I, et al (1989) Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in European families with phenylketonuria (PKU). Am J Hum Genet 45:310–418
Dasovich M, Konecki D, Lichter-Konecki U, Eisensmith RC, Güttler F, Naughton E, Mullins C, Giovanni M, Riva E, Woo SLC (1991) Molecular characterization of the PKU allele prevalent in Southern Europe and Ireland. Somat Cell Mol Genet 17:303–309
DiLella AG, Marvit J, Lidsky AS, Güttler F, Woo SLC (1986) Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. Nature 322:779–803
DiLella AG, Marvit J, Brayton K, Woo SLC (1987) An aminoacid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. Nature 327:333–336
Dworniczak B, Aulehla-Scholz C, Horst J (1989) Phenylketonuria: detection of a frequent haplotype 4 allele mutation. Hum Genet 84:95–96
Dworniczak B, Grudda K, Stumper J, Barholomé K, Aulehla-Scholz C, Horst J (1991) Phenylalanine hydroxylase gene: novel missense mutation in exon 7 causing severe phenylketonuria. Genomics 9:193–199
Economou-Petersen E, Henriksen KF, Guldberg P, Güttler F (1992) Molecular basis for nonphenylketonuria hyperphenylalaninemia. Genomics 14:1–5
Eisensmith RC, Woo SLC (1991) Phenylketonuria and the phenylalanine hydroxylase gene. Mol Biol Med 8:3–18
Eisensmith RC, Woo SLC (1992) Updated listing of haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet 51:1445–1448
Eisensmith RC, Okano Y, Dasovich M, et al (1992) Multiple origins for phenylketonuria in Europe. Am J Hum Genet 51: 1355–1365
Guthrie R (1968) Screening for inborn errors of metabolism in the newborn period: a multiple test program. Birth Defects 4:92–98
Güttler F, Ledley FD, Lidskey AS, DiLella AG, Sullivan SE, Woo SLC (1987) Correlation between polymorphic DNA haplotypes at phenylalanine hydroxylase locus and clinical phenotypes of phenylketonuria. J Pediatr 110:68–71
John SWM, Rozen R, Laframboise R, Laberge C, Scriver CR (1989) Novel PKU mutation on haplotype 2 in French Canadians. Am J Hum Genet 45:905–909
John SWM, Rozen R, Scriver CR, Laframboise R, Laberge C (1990) Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. Am J Hum Genet 46:970–974
Kalaydjieva L, Dworniczak B, Aulehlia-Scholz C, Devoto M, Romeo G, Stuhrmann M, Horst J (1991a) Phenylketonuria mutation in Southern Europeans. Lancet 337:865
Kalaydjieva L, Dworniczak B, Aulehla-Scholz C, Romeo G, Stuhrmann M, Kucinscas V, Yurgelyavicius V, Horst J (1991b). Silent mutations in the phenylalanine hydroxylase gene as an aid to the diagnosis of phenylketonuria. J Med Genet 28:686–690
Kalaydjieva L, Dworniczak B, Kremelski I, Koprivarora K, Radeva B, Milusheva R, Auhelia-Scholz C, Horst J (1992) Heterogeneity of mutations in Bulgarian phenylketonuria haplotype 1 and 4 alleles. Clin Genet 41:123–128
Konecki DS, Lichter-Konecki U (1991) The phenylketonuria locus: current knowledge about alleles of the phenylalanine hydroxylase gene in various populations. Hum Genet 87:377–388
Kwok SCM, Ledley FD, DiLella AG, Robson KJH, Woo SLC (1985) Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Biochemistry 24:556–561
Levy HL, Waisbren SE (1987) The PKU paradigm: the mixed results from early dietary treatment. In: Kaufmann S (ed) Amino acids in health and disease: new perspectives. Liss, New York, pp 539–551
Li J, Eisensmith RC, Wang T, Lo WHY, Huang S-Z, Zeng Y-T, Yuan L-F, Liu S-R, Woo SLC (1992) Identification of three novel missense PKU mutations among Chinese. Genomics 13:894–895
Lichter-Konecki U, Schlotter M, Konecki DJ, Labeit S, Woo SLC, Trefz FK (1988) Linkage disequilibrium between mutation and RFLP haplotype at the phenylalanine hydroxylase locus in the German population. Hum Genet 78:347–352
Lyonnet S, Caillaud C, Rey F, Berthelon M, Frézal J, Rey J, Munnich A (1989) Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency. Am J Hum Genet 44:511–517
Müllerbach R, Lagoda PJL, Welter C (1989) An efficient saltchloroform extraction of DNA from blood and tissues. Trends Genet 5:391
Niederwieser A, Curtius H-Ch, Wang M, Leupold D (1982) Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiaterin, screening and study of biosynthesis in man. Eur J Pediatr 138:110–112
Okano Y, Wang T, Eisensmith RC, Steinmann B, Gitzelmann R, Woo SLC (1990) Missense mutations associated with RFLP aplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet 46:18–25
Okano Y, Eisensmith RC, Güttler F, Lichter-Konecki U, Konecki DS, Trefz FK, Dasovich M, Wang T, Henriksen K, Lou H, Woo SLC (1991) Molecular basis of phenotype heterogeneity in phenylketonuria. N Engl J Med 324:1232–1238
Scriver CR, Kaufmann S, Woo SLC (1988) Mendelian hyperphenylalaninemia. Annu Rev Genet 22:301–322
Wang T, Okano Y, Eisensmith R, Huang S-Z, Zeng Y-T, Lo WHY, Woo SLC (1989) Molecular genetics of phenylketonuria in Orientals: linkage disequilibrium between a termination mutation and haplotype 4 of the phenylalanine hydroxylase gene. Am J Hum Genet 45:675–680
Woo SLC (1988) Collation of RFLP haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet 43: 781–783
Woo SLC, Lidsky AS, Güttler F, Chandra T, Robson KJH (1983) Clones human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria. Nature 306:151–155
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meijer, H., Jongbloed, R.J.E., Hekking, M. et al. RFLP haplotyping and mutation analysis of the phenylalanine hydroxylase gene in Dutch phenylketonuria families. Hum Genet 92, 588–592 (1993). https://doi.org/10.1007/BF00420944
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00420944